Plant ID: NPO927
Plant Latin Name: Swertia mussotii
Taxonomy Genus: Swertia
Taxonomy Family: Gentianaceae
NCBI TaxonomyDB:
137888
Plant-of-the-World-Online:
n.a.
China
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 8.041E-08 | 1.751E-03 | CYP2C19, CYP2D6 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 3.007E-06 | 3.274E-02 | CYP2C19, CYP2D6 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 5.307E-06 | 3.852E-02 | CYP2C19, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0019369; arachidonic acid metabolic process | 7.671E-06 | 4.176E-02 | CYP2C19, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0042737; drug catabolic process | 3.453E-05 | 6.835E-02 | CYP2C19, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 3.453E-05 | 6.835E-02 | CYP2C19, CYP2D6 |
MF | GO:0005488; binding | GO:0020037; heme binding | 4.357E-05 | 7.298E-02 | CYP2C19, CYP2D6 |
MF | GO:0003824; catalytic activity | GO:0016705; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 6.398E-05 | 8.707E-02 | CYP2C19, CYP2D6 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 6.819E-05 | 8.734E-02 | CYP2C19, CYP2D6 |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 2.271E-03 | 1.000E+00 | CYP2C19, CYP2D6 |
CC | GO:0016020; membrane | GO:0031090; organelle membrane | 1.976E-02 | 1.000E+00 | CYP2C19, CYP2D6 |
MF | GO:0005488; binding | GO:0046872; metal ion binding | 4.551E-02 | 1.000E+00 | CYP2C19, CYP2D6 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.173E-05 | 8.211E-05 | CYP2D6, CYP2C19 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 3.108E-05 | 1.088E-04 | CYP2D6, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 6.191E-03 | 9.547E-03 | CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 2.898E-03 | 6.762E-03 | CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 7.287E-03 | 9.547E-03 | CYP2D6 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 8.183E-03 | 9.547E-03 | CYP2C19 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.201E-01 | 1.201E-01 | CYP2C19 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CYP2D6; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6; |
G00-G99: Diseases of the nervous system G00-G99 | Migraine | G43 | CYP2D6; |